New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
14:59 EDTESRX, INSYInsys sinks after analyst sees drug to be excluded from coverage
Shares of Insys Therapeutic (INSY) are falling after Cleveland Research indicated that its checks showed Express Scripts (ESRX) was looking to exclude Insys' Subsys from its list of covered drugs for 2015. Express Scripts is a pharmacy benefits manager. Subsys is intended to provide pain relief for cancer patients. In mid-afternoon trading, Insys tumbled 8% to $27.68.
News For INSY;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
19:14 EDTESRXExpress Scripts to cover both Repatha, Praluent for now, Bloomberg says
Subscribe for More Information
17:08 EDTINSYInsys Therapeutics receives purported service of notice of three IPR petitions
On August 26, Insys Therapeutics received purported service of notice of three inter partes review petitions filed by a hedge fund with the U.S. Patent and Trademark Office, challenging three of the four Orange Book-listed patents covering Subsys. The company intends to oppose the request to institute the IPR and, if any of the three petitions are granted, the company intends to defend the validity of each patent challenged in each IPR.
August 20, 2015
09:20 EDTESRXExpress Scripts rebates to increase due to price protection, says Cleveland
Subscribe for More Information
August 19, 2015
05:46 EDTESRXStocks with implied volatility movement; ESRX BMY
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use